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The effects of apol ipoprotein (a), apol ipoprotein-E, and apol ipoprotein-A4 isoforms on quanti ta-
tive l ipoprotein(a) [Lp(a)] levels were assessed in a sample of 142 Dutch fami l ies consisting of two
parents and thei r  adolescent tw in offspr ing. A total  her i tabi l i ty of 95% was estimated for  plasma
Lp(a) concentrations. The largest par t of this her i tabi l i ty was due to the apo(a) locus which
explained 61% of the total  var iance in Lp(a) levels. The pattern of fami l ial  cor relations for  the
residual  par t of the Lp(a) var iance that could not be attr ibuted to the apo(a) isoforms, suggested
genetic influences on the residual  var iance. We addressed the question whether  this residual
genetic var iance could be ascr ibed to the apoE or  the apoA4 locus. A simul taneous analysis of al l
three loci  showed that both the apoE and the apoA4 polymorphism did not contr ibute significantly
to Lp(a) var iation. Twin Research (2000) 3, 152–158.
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Introduction
Lipoprotein(a) [Lp(a)] is a low-densi ty l ipoprotein
particle wi th an attached apol ipoprotein(a) that was
first described by Berg in 1963.
1
High plasma levels
of Lp(a) are a major risk factor for premature
atherosclerosis, cardiovascular heart disease and
stroke;
2–7
but see also references
8–11
. Quanti tative
Lp(a) levels show large di fferences between individ-
uals that are stable over time and are almost
completely determined by genetic factors as shown
by twin
12–15
and fami ly studies.
16–20
Independent studies have demonstrated that most
of the genetic variabi l i ty in Lp(a) levels can be
explained by genetic heterogenei ty of the apo(a)
locus at chromosome6.
21,22
Codominant al leles at
this locus code for a large number of isoforms that
di ffer in size. There is an inverse relationship
between the size of these isoforms and quanti tative
Lp(a) concentrations. The basis for the size polymor-
phism is the number of kringle4 encoding repeats in
the apo(a) gene.
23
Utermann et al
24
original ly identi -
fied 6 apo(a) isoforms and a nul l  al lele. Boerwinkle et
al
21
estimated that in Caucasians 42% of the vari -
ance in Lp(a) levels is accounted for by these
di fferent isoforms of apo(a). Gaubatz et al
25
found 11
di fferent isoforms and Lackner et al
26
and Kamboh et
al
27
reported methods that detect at least 20 al lel ic
isoforms at the DNA level . Using these methods,
Kraft et al
19
found that the KpnI polymorphism
explained 46% of the variabi l i ty in Lp(a) levels in
Tyrolean subjects. Boerwinkle et al
28
estimated that
the number of kringle4 repeats in the apo(a) gene
accounted for 69% of the Lp(a) variation in Cau-
casian American fami l ies.
The apo(a) size polymorphism is thus a major
determinant of Lp(a) levels, but i t is sti l l  unclear
whether other genetic factors determine variance in
Lp(a) concentrations that cannot be attributed to the
apo(a) locus. Both the apoE and apoA4 polymor-
phisms have been reported to exhibi t a low, but
significant, influence on Lp(a) levels. De Kni jff et al
29
hypothesised that involvement of the LDL receptor
in Lp(a) catabol ism would be supported by an effect
of the apoE locus on Lp(a) levels and found that the
apoE locus accounted for 4% of the phenotypic
variance in Lp(a) levels. Eckardstein et al
30,31
unex-
pectedly observed an effect of the apoA4 locus on
Lp(a) levels in heal thy students and in male coro-
nary heart patients. However, others,
4,19
have main-
tained that, given the Lp(a) l inkage data, i t would be
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highly unl ikely that other loci  than the apo(a) locus
influence plasma Lp(a) levels.
A simul taneous analysis of the influence of the
genetic heterogenei ty at the apo(a), apoE and apoA4
loci  on the plasma levels of Lp(a) wi thin the same
population sample has not yet been attempted. Here
we report the resul ts of such a study. Quanti tative
plasma levels of Lp(a), and apo(a), apoE, and apoA4
size-polymorphisms were measured in 142 Dutch
adolescent mono- and dizogytic tw in pai rs and both
thei r parents, in order to determine whether, in
addi tion to the apo(a) locus, Lp(a) levels are influ-
enced by the apoE- and apoA4 locus.
Mater ials and methods
Subjects
Plasma levels of Lp(a) were assessed in a sample of
160 Dutch mono- and dizygotic tw in pai rs and in
both thei r parents.
13,32
Average age of the twins was
16.7 years (SD = 2.0); average age of thei r parents
was 46.8 years (SD = 6.2). In these same subjects
apo(a) polymorphisms were assessed (isoformsS1,
S2, S3, S4, S5, B and F), as wel l  as apol ipoprotein E
phenotypes (apoE isoformsE2, E3 and E4) and
apol ipoprotein A4 phenotypes (apoA4 isoformsA4-
1, A4-2, A4-3 and A4-0). For five fami l ies no apoE
data were avai lable and for an addi tional  eight
fami l ies the apoA4 polymorphism was not meas-
ured. Five fami l ies were omi tted from the analyses
because one or both parents were non-Caucasian.
This left 142 fami l ies wi th complete data. In these
fami l ies there was an equal  number of males and
females. Zygosi ty of the twin offspring was determi-
nated by blood group antigens and DNA fingerprint-
ing. There were 58 monozygotic (MZ) and 84 dizy-
gotic (DZ) twin pai rs.
Methods
Fasting blood samples were taken between 8.30 and
10.30 am by venipuncture, using Becton-Dickinson
Vacutainers containing sodium-EDTA (Becton Dick-
inson Vacutainer Systems Europe, Meylan, France).
Plasma was immediately separated from the cel ls
and stored in smal l  portions at –20°C unti l  further
use. Apol ipoprotein E and A4 phenotypes were
determined by isoelectric focusing on del ipidated
plasma samples fol lowed by immunoblotting.
33,34
Lp(a) levels were measured wi th a ‘bi -si te sandwich’
ELISA.
13
Apo(a) isoforms were separated using the
Phast System on a 4–15% gradient (PAGE) Phast Gel
(Pharmacia, Uppsala, Sweden) under reducing con-
di tions, for 75 min at 250 V at 15°C. Ten µl  of the
sample was mixed wi th 50 µl , 5% SDS (Biorad,
Hercules, Cal i fornia, USA), 5 µl  mercapto-ethanol
(Biorad), 5 µl  glycerol  (80%) (Merck, Darmstadt,
Germany) containing 0.01% bromophenolblue and
20 µl  glycerol  (80%). The sample was boi led for
3 min and loaded on the gel . After electrophoresis
the gels were blotted by di ffusion for 50 min at 70°C
in a humid sealed petri  dish on to ni trocel lulose
membranes (Hybond - C extra, Amersham-Pharma-
cia Biotech, Rainham, UK) and presoaked for 5 min
in blotting buffer (192 mM glycine, 25 mM Tris HCl ,
20% methanol  at pH 7.4). Residual  binding si tes
were blocked by incubation of the membrane in a
buffer containing 3% BSA, 0.5 M NaCl , 200 mM Tris
HCl , and 0.05% Tween pH 7.4. After washing in PBS
buffer the membranes were incubated for 4 h at room
temperature wi th the anti -Lp(a) antibody at 10 µg/ml
in PBS buffer containing 1% BSA. Since the anti -
Lp(a) antibodies were generated in rabbi ts by immu-
nisation wi th Lp(a) the antisera were purified on an
LDL-affini ty column to el iminate cross-reacting anti -
apo B antibodies. The membrane was washed in PBS
buffer, containing 0.1% BSA and incubated for 2 h at
37°C wi th a peroxidase label led swine anti -rabbi t
antibody (Dakopatts, Glostrup, Denmark) at a
1/300 di lution in PBS buffer + 0.1% BSA. The mem-
brane was washed again and equi l ibrated for 10 mins
in blotting buffer containing methanol . Apo(a) iso-
form bands were revealed by developing for
5–10 minutes wi th 10 mg 4-chloro–1 naphtol  (Merck,
Darmstadt, Germany), dissolved in 3.3 ml  methanol ,
10 µl  H2O2 (Merck, Darmstadt, Germany) and
brought to 17 ml  wi th development buffer (50 mM
Tris HCl , 200 mM NaCl  pH 7.4). The reaction was
stopped by rinsing wi th water. On each gel  an
‘in-house’ serum mix containing the S1, S2, S4, B
and F isoforms (according to the classification by
Utermann et al
24
) was run. In some cases an extra
band above the S4 was identified was as S5.
Statistical analysis
Fisher’s exact test was used to determine i f there
were significant associations between phenotypes at
the apo(a), apoE and apoA4 loci .
35
To test the effects of the polymorphisms at the
three measured loci  on Lp(a) levels, a pedigree-based
maximum l ikel ihood method developed by Lange et
al
36
was used. For a given pedigree of n individuals
a vector of observations (x) was defined and a vector
of expected values (E(x)), that depended on fixed
variables such as age, sex or phenotype. The covar-
iances between fami ly members for the residual  part
of the observations, ie the part not accounted for by
the fixed variables, depend on the relationships
between the pedigree members and on the genetic
model  assumed for the observations. Throughout we
model led the variance not accounted for by the fixed
variables as consisting of addi tive genetic and
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random envi ronmental  variance. In an earl ier analy-
sis of plasma Lp(a) levels, we excluded the possibi l -
i ty that part of the fami l ial  variance may reflect
envi ronmental  influences shared by fami ly
members.
13
For a given E(x) and expected covariance matrix S,
the log-l ikel ihood of obtaining the observation vec-
tor x is:
L = –
1
2ln| S|  –
1
2(x – E(x))' S
–1
(x – E(x)) +
constant
where | |  denotes the determinant of the matrix and
' denotes transpose.
The joint log-l ikel ihood of obtaining al l  142 pedi -
grees is the sum of the log-l ikel ihood of the separate
pedigrees. Estimation involves selection of parame-
ter values under a specific model  which maximizes
the joint l ikel ihood of al l  pedigrees. The FISHER
package
36
was used for genetic model l ing. The
effects of the apo(a), the apoE and the apoA4 locus
on logari thmical ly transformed Lp(a) levels were
considered simul taneously by estimating 107 param-
eters for al l  possible combinations of the phenotypes
at the three loci . Next, a mean effect for each
phenotype at each of the three loci  (25, 6 and 5
di fferent means for apo(a), apoE and apoA4, respec-
tively) was estimated and the effect of each locus
summed across loci . The di fference in l ikel ihood
between these two models provides a test of inter-
action (epistasis) between the three loci . The sig-
nificant contribution of each locus to variation in
Lp(a) levels was evaluated separately by testing
submodels that specified no effects of the apo(a), the
apoE or the apoA4 locus, respectively. The l ike-
l ihoods obtained for di fferent models were com-
pared wi th chi -squared di fference tests where
2 = 2(L1-L0). L1 and L0 denote the log-l ikel ihoods of
the general  (H1) and a constrained (H0) hypothesis.
The degrees of freedom (df) for this test are equal  to
the number of constrained parameters between H1
and H0.
37
Resul ts
In the total  sample of parents and chi ldren we
observed 25 di fferent apo(a) phenotypes, wi th the S4
phenotype being the most frequent (20.6%). The
relative frequencies of the apo(a) phenotypes and the
corresponding Lp(a) levels for each apo(a) pheno-
type are given in Table1. Table1 also presents the
relative frequencies for the apoE and the apoA4 loci ,
as wel l  as the observed average Lp(a) concentrations
for each of these phenotypes. There were no sig-
nificant associations between apo(a), apoE and
apoA4 phenotypes (Fisher’s exact test, P = 0.49 for
apo(a)-apoA4, P = 0.13 for apo(a)-apoE, and P = 0.68
for apoA4-apoE association).
Log-l ikel ihoods for several  models testing the
effects of sex and age on Lp(a) levels and for models
Table 1 Average Lp(a) concentrations in mg/dl  for apo(a), apoE and apoA4 phenotypes in 568 subjects from 142 fami l ies
By apo(a) Phenotype By apoE Phenotype By apoA4 Phenotype
Mean Cases Mean Cases Mean Cases
N % N % N %
nul l 1.03 70 12.3 2/2 5.03 4 0.7 1/1 14.30 486 85.6
S1 24.27 12 2.1 3/2 10.38 97 17.1 1/2 12.17 75 13.2
S2 28.17 58 10.2 3/3 14.53 324 57.0 2/2 1.53 3 0.5
S3 10.67 67 11.8 4/3 16.41 124 22.0 3/1 33.80 3 0.5
S4 8.80 117 20.6 4/4 22.46 7 1.2 1/0 0.70 1 0.2
S5 4.43 64 11.3 4/2 2.67 11 1.9
B 18.85 2 0.4
F 50.30 3 0.5
S1/S2 28.55 2 0.4
S1/S3 39.60 2 0.4
S1/S4 31.31 9 1.6
S1/S5 31.71 8 1.4
S2/S3 24.16 16 2.8
S2/S4 25.10 26 4.6
S2/S5 16.95 19 3.3
S3/S4 11.32 27 4.8
S3/S5 9.65 24 4.2
S4/S5 7.61 24 4.2
B/S2 104.80 2 0.4
B/S3 14.90 1 0.2
B/S4 41.44 5 0.9
B/S5 28.00 4 0.7
B/F 46.00 2 0.4
F/S4 40.25 2 0.4
F/S5 141.00 2 0.4
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testing di fferent hypotheses about fami l ial  resem-
blance are given in Table2. There were no sex or
generation di fferences in Lp(a) levels, and no asso-
ciations wi th age. The spouse correlation between
Lp(a) levels of fathers and mothers was not di fferent
from zero. The MZ correlation (r = 0.95) was twice
the DZ correlation (r = 0.47), and the parent–off-
spring correlation could be set equal  to the DZ
correlation, indicating a heri tabi l i ty of 95% for
quanti tiatve Lp(a) levels, that was the same in both
generations.
In Table3 l ikel ihood-ratio tests for the effects of
the apo(a), apoE and apoA4 polymorphism on Lp(a)
concentrations are summarised. Table3 first gives
the log-l ikel ihood for a general  model  that estimated
107 separate means for al l  possible combinations of
the phenotypes at the apo(a), apoE and apoA4 loci .
The next model  specified the effects of the three loci
to act addi tively. The relatively large decrease in
l ikel ihood for this model  is accompanied by a large
number of degrees of freedom and is not significant.
This test indicates that there is no interaction
between the three loci  w i th respect to Lp(a) levels.
That is, the effect of the apo(a) locus on Lp(a)
concentrations is not dependent on a subject’s apoE
or apoA4 phenotype. The apo(a) isoforms had a
highly significant effect on Lp(a) concentrations, as
indicated by the significant decrease in l ikel ihood,
for the model  in which al l  apo(a) phenotypes were
constrained to have the same average Lp(a) concen-
tration. The apo(a) locus explained 61% of the
variance in Lp(a) levels. The MZ, DZ and parent–
offspring correlations for the residual  part of the
variance were estimated as 0.87, 0.32, and 0.33,
respectively. The next two entries in Table3 show
that both the apoE and the apoA4 locus did not
contribute significantly to Lp(a) variation, as there
was a non-significant decrease in l ikel ihood when
these effects were omi tted from the model .
Discussion
We found an addi tive genetic heri tabi l i ty of 95% for
quanti tative Lp(a) plasma levels in unselected Dutch
fami l ies consisting of parents and thei r tw in off-
spring. This heri tabi l i ty estimate is very simi lar to
the estimates we obtained previously in this
13
and
other Dutch samples
15
using a structural  model l ing
approach to analyse the data and also closely
resembles estimates from other fami ly studies. Size
heterogenei ty of the Lp(a) polypeptide chain was
associated wi th quanti tative Lp(a) plasma levels. A
major part (61%) of the variance in Lp(a) levels in
this sample could be attributed to the di fference
apo(a) isoforms. The detection of apo(a) isoforms at
the protein level  as used by us, is not as sensi tive as
the pulsed-field electrophoretic method developed
by Lackner et al
26
that can detect 20 or more al leles
at the DNA level  and represents a size category
Table 2 Log-l ikel ihoods for di fferent models testing the signi ficance of sex and age on log-transformed Lp(a) levels. Tests on the
covariance structure between fami ly members include a test of assortative mating (correlation between spouses), of addi tive genetic
influences (rMZ = 2rDZ) and of equal  heri tabi l i ty in parental  and offspring generations (rDZ = rparent–offspring)
Difference test
Log-likelihood df 2
General  model 198.178 – –
Same means for both generations and both sexes 196.292 3 3.772
No association with age 196.159 1 0.266
No correlation between spouses 195.951 1 0.416
MZ correlation equals 2 *  DZ correlation 195.915 1 0.072
DZ correlation equals parent-offspring correlation 194.707 1 2.416
Al l  models were tested against the preceding model. Al l  decreases in l ikel ihood were non-signi ficant (cri tical  value for 2 wi th 3 df is 7.18
and for 1 df 3.84). The general  model estimated separate means for fathers, mothers, sons and daughters, a l inear regression of Lp(a) levels
on age and separate correlations between spouses, parents and offspring, MZ and DZ twins.
Table 3 Simultaneous analyses of the effects of the apo(a), apoE and apoA4 loci  on log-transformed Lp(a) levels. Separate MZ, DZ and
parent–offspring correlations and no correlation between spouses were estimated for the residual  variances
Difference test
Log-likelihood df 2
1 General  model 452.689 – –
2 Additive effects of phenotypes at 3 loci 412.112 73 81.154
3 No effect of apo(a) locus 213.962 24 396.30a
4 No effect of apoA4 locus 408.780 4 6.664
5 No effect of apoE locus 408.388 5 7.448
asigni ficant decrease in l ikel ihood (cri tical  value for 2 wi th 73 df is 93.94, for 4 df 9.48, and for 5 df 11.07). Model 2 is tested against
model 1; models 3, 4 and 5 are tested against model 2. The general  model estimated separate means for al l  possible combinations of the
phenotypes at the apo(a), apoE and apoA4 loci .
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rather than one distinct species. However, the per-
centages of variance explained by the apo(a) size
polymorphism, as measured by the di fferent apo(a)
isoforms in our study and by the 16 di fferent apo(a)
al leles in the study of Boerwinkle et al
28
are
remarkably simi lar. Boerwinkle et al reported that
69% of the variation in Lp(a) levels was explained by
the number of kringle4 repeats in the apo(a) gene,
whereas we found 61%. This simi lari ty in resul ts
agrees wi th the perfect correlation reported by Kraft
et al
19
between apo(a) protein isoforms and apo(a)
al lele size.
The pattern of fami l ial  correlations for the residual
part of the Lp(a) variance that could not be attributed
to the apo(a) isoforms suggested genetic influences
on the residual  variance, as the MZ correlation (0.87)
was larger than the DZ and parent–offspring correla-
tions (0.32 and 0.33). We addressed the question
whether the residual  genetic variance that is not
accounted for by the apo(a) size polymorphism is
caused by genetic heterogenei ty at other loci . Two
other loci  have been suggested, the apoE locus at
chromosome19 and the apoA4 locus at chromo-
some11. In an earl ier analysis of the Lp(a) levels in
the parents from our twin fami l ies, we found that a
smal l  part (4%) of the Lp(a) variance was due to the
apoE locus.
29
Simi lar effects have been reported by
others. In the EARS study, Ti ret et al
38
found a
significant lowering effect on the apoE2 al lele on
Lp(a) concentrations in almost 1900 young adul ts
from 11 European countries. Lindahl  et al
39
used a
crude form of correcting Lp(a) levels for apo(a)
phenotype, using part of a sample of 149 patients
wi th fami l ial  hypercholesterolaemia. No effect of
apoE phenotype was seen on residual  Lp(a) levels,
but the number of patients wi th residual  Lp(a) levels
below the median was larger in the E2 + group and
lower in the E4 + group. In contrast, in the Framing-
ham offspring study apoE phenotype was not asso-
ciated wi th plasma Lp(a) concentrations.
40
Two
other studies also did not observe this association. In
patients wi th myocardial  infarction
41
and in patients
wi th fami l ial  hypercholesterolaemia
42
no apoE effect
on Lp(a) levels was detected.
Eckardstein et al
30,31
obtained evidence that the
apoA4 locus influences Lp(a) concentrations. The
effect was shown in two independent samples,
consisting of heal thy males and females and of male
coronary heart patients. ApoA4 explained around
5% of the Lp(a) variance in patients. However, a
negative resul t was found in the EARS study. No
association between apoA4 phenotype and Lp(a)
levels was seen.
43
The data on the influences of the genetic heteroge-
nei ty at the apoE and the apoA4 locus on plasma
Lp(a) levels thus are inconsistent. We found in our
data that the apoE locus explained 6% of the apoA4
locus 3% of the variation in Lp(a) concentrations
where we analysed the effects of apoE and apoA4
independent from those of the apo(a) locus. How-
ever, when the effect of the apo(a) locus was
included in the model  (after obtaining evidence that
the effects of the apo(a), apoE and apoA4 loci  did not
interact) the effects of apoE and apoA4 phenotype on
Lp(a) levels were not significant. This suggests that
the earl ier posi tive findings, obtained in data that
were not adjusted for di fferences in apo(a) pheno-
types between subjects, may have been arti facts.
If genetic factors account for more than 90% of the
variance in Lp(a) levels and the apo(a) size polymor-
phism explains 61% of the total  Lp(a) variation, then
a substantial  part of the genetic variance must be
caused by genetic factors other than the size poly-
morphism i tsel f. Evidence from the studies by Kraft
et al
19
and Boerwinkle et al
28
suggests that genetic
factors l inked to the apo(a) gene determine Lp(a)
variation. Both these studies observed that the
correlation for Lp(a) levels among sibl ings who
shared both apo(a) al leles identical  by descent, was
as high as Lp(a) heri tabi l i ty, whereas correlations
among sibl ings sharing only one or no al leles
identical  by descent were significantly lower. These
observations and the resul ts from our own study
suggest that the remainder of the Lp(a) variance is
not accounted for by the apoE or apoA4 locus, but
may be caused by di fferences in the whole process of
Lp(a) production, eg transcription of the apo(a) gene,
including trans-acting factors and cis-acting pro-
moter sequences at the apo(a) locus, stabi l i ty of the
apo(a) mRNA, apo(a) protein translation, intracel -
lular processing, transport and secretion of the
protein, and assembly into a Lp(a) particle. This
view is supported by the observation that the
substantial  variation in Lp(a) levels among individ-
uals wi th the same apo(a) phenotype is caused
primari ly by di fferences in Lp(a) production rate.
44
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